Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Listen to more of the conversation with Barb Stuckey on IFTs Omnivore podcast and read about the impact of anti-obesity drugs in the March issue of Food Technology magazine
Key trials studied the compounds themselves STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)
However, that interest dropped to only 16% if they were told the drug was not covered by insurance
Users may experience gastrointestinal disturbances, such as nausea, vomiting, diarrhea, and constipation, particularly in the early stages of treatment
US$ 23.57
US$ 23.96
US$ 29.40
